Title:
CRYSTAL FORM OF EGFR INHIBITOR AND PREPARATION METHOD THEREFOR
Document Type and Number:
WIPO Patent Application WO/2020/207483
Kind Code:
A1
Abstract:
Disclosed are a crystal form of an EGFR inhibitor and a preparation method therefor. Further disclosed is an application of the crystal form in preparing a drug for treating non-small cell lung cancer, especially an application in preparing a drug for treating non-small cell lung cancer with brain metastases.
Inventors:
LIU XILE (CN)
ZHANG LU (CN)
DING CHARLES Z (CN)
CHEN SHUHUI (CN)
HU LIHONG (CN)
ZHANG LU (CN)
DING CHARLES Z (CN)
CHEN SHUHUI (CN)
HU LIHONG (CN)
Application Number:
PCT/CN2020/084286
Publication Date:
October 15, 2020
Filing Date:
April 10, 2020
Export Citation:
Assignee:
MEDSHINE DISCOVERY INC (CN)
International Classes:
C07D498/10; A61K31/505; A61P35/00
Domestic Patent References:
WO2020007219A1 | 2020-01-09 | |||
WO2018143315A1 | 2018-08-09 |
Foreign References:
CN108640928A | 2018-10-12 | |||
CN103172641A | 2013-06-26 | |||
CN201910285738A | 2019-04-10 |
Other References:
See also references of EP 3954693A4
Attorney, Agent or Firm:
SHANGHAI BESHINING LAW OFFICE (CN)
Download PDF:
Previous Patent: OBJECT CARRYING APPARATUS USED IN VEHICLE
Next Patent: OCCLUDER, OCCLUDER FASTENING SYSTEM AND FASTENING METHOD
Next Patent: OCCLUDER, OCCLUDER FASTENING SYSTEM AND FASTENING METHOD